Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance : Current Opinion in Rheumatology

Secondary Logo

Journal Logo

EPIDEMIOLOGY AND HEALTH-RELATED SERVICES: Edited by Kenneth G. Saag

Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance

Robinson, Philip C.; Yazdany, Jinoos; Machado, Pedro M.

Author Information
Current Opinion in Rheumatology 33(2):p 111-116, March 2021. | DOI: 10.1097/BOR.0000000000000783

Abstract

Purpose of review 

This review discusses the coronavirus disease-2019 (COVID-19) Global Rheumatology Alliance (GRA), the reason for its formation, the challenges with running the registry, and future opportunities for global collaborative research in rheumatology.

Recent findings 

The GRA has been successful in collecting and publishing a large volume of case data on patients with rheumatic disease with COVID-19. In addition, the GRA has published reviews, opinion pieces, and patient-directed summaries of research to further assist in disseminating timely and accurate information about COVID-19 in rheumatic diseases. There have been numerous challenges in the journey but they have been addressed through a collaborative problem-solving approach.

Summary 

The initial objectives of the GRA to describe the outcomes in patients with rheumatic disease who developed COVID-19 have been achieved. There has been extensive use of the data in the clinic and also to try and understand the mechanisms of disease and opportunities for drug repurposing. There remain numerous important areas for research which the GRA will continue to pursue as the pandemic evolves.

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid